Key facts
- This page summarizes Alperovitz Asaf's Form 4 filing for ICL Group Ltd. (ICL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Aug 2026, 16:03.
Alperovitz Asaf - 04 Aug 2026 Form 4 Insider Report for ICL Group Ltd. (ICL)
- Reporting relationship
- ICL CFO
- Issuer ticker
- ICL
- Reported as of
- 04 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Aug 2026, 16:03:08 UTC
- Prior SEC filing
- 17 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alperovitz Asaf
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Alperovitz Asaf filed Form 4 for ICL Group Ltd. (ICL) on 05 Aug 2026.
Change
- Previous filing in this sequence was filed on 17 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001449373
Primary reporting owner
Alperovitz Asaf
- Relationship
- ICL CFO
- Address
- C/O ICL GROUP LTD., LANDMARK TOWER, 2 LEONARDO DA VINCI ST., TEL AVIV, ISRAEL
- Signature
- /s/ Alperovitz Asaf
- Signature date
- 05 Aug 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ICL
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- Shares
- +1,829,268
- Change %
- Price
- $0.000000*
- Shares after
- 1,829,268
- Date
- 04 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 1,829,268
- Exercise price
- $5.05
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents an exercise price of NIS 15.31, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.0300 as of 8/4/2026.
Footnote F2
The stock options vest in three equal annual installments from the 8/4/2026 grant date.
Footnote F3
The options are held by a Trustee in the name of the Reporting Person.